Bibliography
- Kuehnert MJ . Methicillin-resistant-Staphylococcus aureus hospitalizations, United States. Emerg. Infect. Dis.11(6), 868–872 (2005).
- Klevens RM , MorrisonMA, NadleJet al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298(15), 1763–1771 (2007).
- Klein E , SmithDL, LaxminarayanR. Community-associated methicillin-resistant Staphylococcus aureus in outpatients, United States, 1999–2006. Emerg. Infect. Dis.15(12), 1925–1930 (2009).
- Gilbert DN , GuidosRJ, BoucherHWet al. The 10 × ´20 initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020. Clin. Infect. Dis. 50(8), 1081–1083 (2010).
- Rasko DA , SperandioV. Anti-virulence strategies to combat bacteria-mediated disease.Nat. Rev. Drug Discov.9(2), 117–128 (2010).
- Cegelski L , MarshallGR, EldridgeGR, HultgrenSJ. The biology and future prospects of antivirulence therapies.Nat. Rev. Micro.6(1), 17–27 (2008).
- Queck SY , Jameson-LeeM, VillaruzAEet al. RNAIII-independent target gene control by the agr quorum-sensing system: insight into the evolution of virulence regulation in Staphylococcus aureus. Mol. Cell 32(1), 150–158 (2008).
- George EA , NovickRP, MuirTW. Cyclic peptide inhibitors of Staphylococcal virulence prepared by Fmoc-based thiolactone peptide synthesis. JACS130(14), 4914–4924 (2008).
- Khodaverdian V , PeshoM, TruittB, BollingerL, PatelP, Shoham,M. Discovery of antipathogenic agents against MRSA. Presented at: Interscience Conference on Antimicrobial Agents and Chemotherapy Meeting. Boston, MA, USA, 12–15 September 2010.
- Pishchany G , McCoyAL, TorresVJet al. Specificity for human hemoglobin enhances Staphylococcus aureus infection. Cell Host Microbe 8(6), 544–550 (2010).
- Kennedy AD , Bubeck WardenburgJ, GardnerDJet al. Targeting of α-hemolysin by active or passive immunization decreases severity of USA300 skin infection in a mouse model. J. Infect. Dis.202(7), 1050–1058 (2010).
- Ragle BE , Bubeck Wardenburg J. Anti-α- hemolysin monoclonal antibodies mediate protection against Staphylococcus aureus pneumonia. Infect. Immun.77(7), 2712–2718 (2009).
- Qiu J , FengH, LuJet al. Eugenol reduces the expression of virulence-related exoproteins in Staphylococcus aureus. Appl. Environ. Microbiol. 76(17), 5846–5851 (2010).
- Qiu J , FengH, XiangHet al. Influence of subinhibitory concentrations of licochalcone A on the secretion of enterotoxins A and B by Staphylococcus aureus. FEMS Microbiol. Lett. 307(2), 135–141 (2010).
- Qiu J , WangD, XiangHet al. Subinhibitory concentrations of thymol reduce enterotoxins A and B and α-hemolysin production in Staphylococcus aureus isolates. PLoS One 5(3), e9736 (2010).
- Qiu J , LuoM, DongJet al. Menthol diminishes Staphylococcus aureus virulence-associated extracellular proteins expression. Appl. Microbiol. Biotechnol. 90(2), 705–712 (2011).
- Qiu J , ZhangX, LuoMet al. Subinhibitory concentrations of perilla oil affect the expression of secreted virulence factor genes in Staphylococcus aureus. PLoS One 6(1), e16160 (2011).
- Xiang H , QiuJZ, WangDC, JiangYS, XiaLJ, DengXM. Influence of magnolol on the secretion of α-toxin by Staphylococcus aureus. Molecules15(3), 1679–1689 (2010).
- Ragle BE , KarginovVA, Bubeck Wardenburg J. Prevention and treatment of Staphylococcus aureus pneumonia with a β-cyclodextrin derivative. Antimicrob. Agents Chemother.54(1), 298–304 (2010).
- Montoya MT , SliwinskiJ, Yeaman,MR, BayerAS, MercierRC. Diflunisal decreases S. aureus colonization and proliferation in an in vitro model of infective endocarditis. Presented at: Interscience Conference on Antimicrobial Agents and Chemotherapy Meeting. Boston, MA, USA, 12–15 September 2010.
Website
- Mark Stibich. MRSA Infection Statistics. http://longevity.about.com/od/optimizemedicalcare/a/mrsa_infections_2.htm